Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LOPINAVIR; RITONAVIR

LOPINAVIR; RITONAVIR

Standard Dose
80MG; 20MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview LOPINAVIR; RITONAVIR is listed in Drugs@FDA under application 091203 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient LOPINAVIR; RITONAVIR Form and strength SOLUTION; ORAL - 80MG; 20MG Sponsor CIPLA LIMITED Submission history Latest submission status date: 2012-06-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOPINAVIR; RITONAVIR is listed in Drugs@FDA under application 091203 (ANDA). Marketing status: None (Tentative Approval) Active ingredient LOPINAVIR; RITONAVIR Form and strength SOLUTION; ORAL - 80MG; 20MG Sponsor CIPLA LIMITED Submission history Latest submission status date: 2012-06-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
LOPINAVIR; RITONAVIR (LOPINAVIR; RITONAVIR) | Drug Monograph | MedicHelpline